BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15219317)

  • 1. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
    Thomas Dickey D; Muldoon LL; Kraemer DF; Neuwelt EA
    Hear Res; 2004 Jul; 193(1-2):25-30. PubMed ID: 15219317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
    Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
    Nader ME; Théorêt Y; Saliba I
    Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine attenuates noise-induced permanent hearing loss in diabetic rats.
    Wu HP; Hsu CJ; Cheng TJ; Guo YL
    Hear Res; 2010 Aug; 267(1-2):71-7. PubMed ID: 20430080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
    Okur E; Kilinc M; Yildirim I; Kilic MA; Tolun FI
    Laryngoscope; 2007 Dec; 117(12):2183-6. PubMed ID: 17909450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of noise conditioning on cisplatin-induced ototoxicity: a pilot study.
    Theneshkumar S; Lorito G; Giordano P; Petruccelli J; Martini A; Hatzopoulos S
    Med Sci Monit; 2009 Jul; 15(7):BR173-7. PubMed ID: 19564816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
    Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose and time-dependent protection of the antioxidant N-L-acetylcysteine against impulse noise trauma.
    Duan M; Qiu J; Laurell G; Olofsson A; Counter SA; Borg E
    Hear Res; 2004 Jun; 192(1-2):1-9. PubMed ID: 15157958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different strategies in treating noiseinduced hearing loss with N-acetylcysteine.
    Lorito G; Giordano P; Petruccelli J; Martini A; Hatzopoulos S
    Med Sci Monit; 2008 Aug; 14(8):BR159-64. PubMed ID: 18667992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoguanidine prevents ototoxicity induced by cisplatin in rats.
    Iraz M; Kalcioglu MT; Kizilay A; Karatas E
    Ann Clin Lab Sci; 2005; 35(3):329-35. PubMed ID: 16081592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
    Feghali JG; Liu W; Van De Water TR
    Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
    Sockalingam R; Freeman S; Cherny TL; Sohmer H
    Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
    Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
    Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
    Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
    Tokgoz B; Ucar C; Kocyigit I; Somdas M; Unal A; Vural A; Sipahioglu M; Oymak O; Utas C
    Nephrol Dial Transplant; 2011 Dec; 26(12):4073-8. PubMed ID: 21551083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity.
    Abdelrahman AM; Al Salam S; AlMahruqi AS; Al husseni IS; Mansour MA; Ali BH
    J Appl Toxicol; 2010 Jan; 30(1):15-21. PubMed ID: 19681060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
    Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
    Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.